A double-blind, placebo-controlled study to determine the effects of risedronate on bone loss in glucocorticoid-treated rheumatoid arthritis patients

✍ Scribed by R. Eastell; J. P. Devogelaer; N. F. A. Peel; C. Gill; D. E. Bax; C. Nagant de Deuxchaisnes; R. G. G. Russell

• Publisher: Springer-Verlag
• Year: 1996
• Tongue: English
• Weight: 140 KB
• Volume: 6
• Category: Article
• ISSN: 0937-941X
• DOI: 10.1007/bf02499923